Post-marketing Safety Evaluation of S-1 in Patients with Inoperable or Recurrent Breast Cancer: Especially in Patients Treated with S-1 + Trastuzumab

OBJECTIVE: The purpose of this study was to assess the safety of S-1 in Japanese in inoperable or recurrent breast cancer patients. METHODS: A prospective post-marketing surveillance was performed at 313 sites in Japan in patients with inoperable or recurrent breast cancer treated with S-1. We exami...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yuki, Oshitanai, Risa, Terao, Mayako, Terada, Mizuho, Tsuda, Banri, Okamura, Takuho, Suzuki, Yasuhiro, Tokuda, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163436/
https://www.ncbi.nlm.nih.gov/pubmed/21810868
http://dx.doi.org/10.1093/jjco/hyr099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163436/
https://www.ncbi.nlm.nih.gov/pubmed/21810868
http://dx.doi.org/10.1093/jjco/hyr099

Ejemplares similares